In one study, the carriage of non-synonymous polymorphisms of NOD1 (rs2075820 [p.E266K]) and NOD2 (rs2066842 [p.S268P]) was examined for links with metabolic syndrome and insulin resistance in 998 Canadians aged 20–29 [5]. Here, NOD2 is linked to metabolic syndrome.